SI2680873T1 - Protiglivna sredstva in njihova uporaba - Google Patents

Protiglivna sredstva in njihova uporaba

Info

Publication number
SI2680873T1
SI2680873T1 SI201231096T SI201231096T SI2680873T1 SI 2680873 T1 SI2680873 T1 SI 2680873T1 SI 201231096 T SI201231096 T SI 201231096T SI 201231096 T SI201231096 T SI 201231096T SI 2680873 T1 SI2680873 T1 SI 2680873T1
Authority
SI
Slovenia
Prior art keywords
antifungal agents
antifungal
agents
Prior art date
Application number
SI201231096T
Other languages
English (en)
Inventor
Kenneth Duke James Jr.
Christopher Patrick Laudeman
Navdeep Balkrishna Malkar
Balasingham Radhakrishnan
Original Assignee
Cidara Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cidara Therapeutics, Inc. filed Critical Cidara Therapeutics, Inc.
Publication of SI2680873T1 publication Critical patent/SI2680873T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
SI201231096T 2011-03-03 2012-03-02 Protiglivna sredstva in njihova uporaba SI2680873T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161448807P 2011-03-03 2011-03-03
PCT/US2012/027451 WO2012119065A2 (en) 2011-03-03 2012-03-02 Antifungal agents and uses thereof
EP12751994.0A EP2680873B1 (en) 2011-03-03 2012-03-02 Antifungal agents and uses thereof

Publications (1)

Publication Number Publication Date
SI2680873T1 true SI2680873T1 (sl) 2017-12-29

Family

ID=46758514

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201231096T SI2680873T1 (sl) 2011-03-03 2012-03-02 Protiglivna sredstva in njihova uporaba

Country Status (17)

Country Link
US (5) US8722619B2 (sl)
EP (2) EP2680873B1 (sl)
JP (4) JP5809296B2 (sl)
CN (2) CN106279369B (sl)
CA (2) CA3053850A1 (sl)
CY (1) CY1119709T1 (sl)
DK (1) DK2680873T3 (sl)
ES (1) ES2645074T3 (sl)
HR (1) HRP20171579T8 (sl)
HU (1) HUE036778T2 (sl)
LT (1) LT2680873T (sl)
NO (1) NO2680873T3 (sl)
PL (1) PL2680873T3 (sl)
PT (1) PT2680873T (sl)
RS (1) RS56426B1 (sl)
SI (1) SI2680873T1 (sl)
WO (1) WO2012119065A2 (sl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5809296B2 (ja) 2011-03-03 2015-11-10 シーチェイド ファーマシューティカルズ,インコーポレーテッド 抗真菌薬及びそれらの使用
ES2957620T3 (es) * 2012-03-19 2024-01-23 Cidara Therapeutics Inc Regímenes de dosificación para los compuestos de la clase de las equinocandinas
WO2015035102A2 (en) * 2013-09-04 2015-03-12 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
AU2015253484A1 (en) * 2014-04-28 2016-10-06 University Of Central Florida Research Foundation, Inc. Compositions, methods of making a composition, and methods of use
WO2016201283A1 (en) * 2015-06-12 2016-12-15 Cidara Therapeutics, Inc. Antifungal agents
US20180256673A1 (en) * 2015-09-16 2018-09-13 Cidara Therapeutics, Inc. Methods for treating fungal infections
CN106674333B (zh) * 2015-11-06 2020-10-27 博瑞生物医药(苏州)股份有限公司 一种环肽类抗真菌化合物及其制备方法
CN108883152A (zh) 2016-01-08 2018-11-23 奇达拉治疗公司 防止和治疗肺孢子虫感染的方法
MA43825A (fr) * 2016-03-16 2021-04-07 Cidara Therapeutics Inc Schémas posologiques pour le traitement d'infections fongiques
WO2018102407A1 (en) * 2016-11-29 2018-06-07 Cidara Therapeutics, Inc Methods for preventing fungal infections
JP2020505427A (ja) * 2017-01-31 2020-02-20 シダラ セラピューティクス インコーポレーテッド 真菌感染症を治療する方法
JP2020529973A (ja) * 2017-07-12 2020-10-15 シダラ セラピューティクス インコーポレーテッド 真菌感染症の処置のための組成物及び方法
US11524980B2 (en) 2018-06-15 2022-12-13 Cidara Therapeutics, Inc. Synthesis of echinocandin antifungal agent
US20210355165A1 (en) * 2018-10-25 2021-11-18 Cidara Therapeutics, Inc. Polymorph of echinocandin antifungal agent
CA3161287A1 (en) 2019-12-06 2021-06-10 Shanghai Senhui Medicine Co., Ltd. Echinocandin analogues and preparation method therefor
EP4349851A1 (en) 2021-06-03 2024-04-10 Shanghai Senhui Medicine Co., Ltd. Method for preparing anidulafungin derivative
CN116903706A (zh) * 2023-06-13 2023-10-20 深圳市祥根生物有限公司 一种棘白菌素类药物及其制备方法和用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030944A (en) * 1991-10-01 2000-02-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compounds
US5399552A (en) 1991-10-17 1995-03-21 Merck & Co, Inc Antibiotic peptides bearing aminoalkylthioether moieties
US5378804A (en) 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US6268338B1 (en) 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
CA2161149A1 (en) 1993-05-04 1994-11-10 James M. Balkovec Cyclohexapeptidyl aminoalkyl ethers
US5948753A (en) 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
AU7874494A (en) * 1993-09-22 1995-04-10 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5541160A (en) * 1994-04-04 1996-07-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5514651A (en) 1994-09-16 1996-05-07 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5516756A (en) 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
EP0805685B1 (en) 1995-01-26 2001-09-26 Merck & Co., Inc. Novel antifungal cyclohexapeptides
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
IL143563A0 (en) * 1998-12-09 2002-04-21 Lilly Co Eli Purification of echinocandin cyclopeptide compounds
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1345230A (zh) 1999-03-03 2002-04-17 伊莱利利公司 口服ecb药物制剂和药物组合物的制备方法
US6610822B2 (en) 2000-09-01 2003-08-26 Merck & Co., Inc. Purification process
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
WO2005018743A1 (en) * 2003-07-22 2005-03-03 Theravance, Inc. Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
US20070231258A1 (en) * 2006-03-31 2007-10-04 Karyon Ctt Ltd. Peptide conjugates
US20090238867A1 (en) 2007-12-13 2009-09-24 Scott Jenkins Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
GB0817121D0 (en) 2008-09-18 2008-10-29 Univ St Andrews Anti-fungal therapy
US9006391B2 (en) * 2009-05-07 2015-04-14 Dsm Sinochem Pharmaceuticals Netherlands B.V. Method for the preparation of cyclopeptides
US20120190613A1 (en) 2009-08-27 2012-07-26 James Jr Kenneth Duke Echinocandin derivatives
EP2525831B1 (en) 2010-01-22 2019-05-15 Ascendis Pharma A/S Carrier-linked carbamate prodrug linkers
JP5809296B2 (ja) * 2011-03-03 2015-11-10 シーチェイド ファーマシューティカルズ,インコーポレーテッド 抗真菌薬及びそれらの使用

Also Published As

Publication number Publication date
WO2012119065A2 (en) 2012-09-07
US8722619B2 (en) 2014-05-13
EP2680873A2 (en) 2014-01-08
HUE036778T2 (hu) 2018-07-30
PT2680873T (pt) 2017-11-01
CN106279369A (zh) 2017-01-04
WO2012119065A3 (en) 2014-03-13
JP2016029052A (ja) 2016-03-03
CN103889221B (zh) 2016-08-31
US9217014B2 (en) 2015-12-22
EP2680873B1 (en) 2017-08-09
NO2680873T3 (sl) 2018-01-06
EP3192803B1 (en) 2020-12-09
JP5809296B2 (ja) 2015-11-10
ES2645074T8 (es) 2018-09-28
US20170253635A1 (en) 2017-09-07
CA2865791C (en) 2019-10-08
CA3053850A1 (en) 2012-09-07
PL2680873T3 (pl) 2018-01-31
US9676821B2 (en) 2017-06-13
US20160075740A1 (en) 2016-03-17
LT2680873T (lt) 2017-11-27
JP6302108B2 (ja) 2018-03-28
CN106279369B (zh) 2020-02-11
CN103889221A (zh) 2014-06-25
RS56426B1 (sr) 2018-01-31
JP6111447B2 (ja) 2017-04-12
US20220162263A1 (en) 2022-05-26
CY1119709T1 (el) 2018-06-27
JP2018118977A (ja) 2018-08-02
ES2645074T3 (es) 2017-12-04
EP2680873A4 (en) 2015-08-26
US20130244930A1 (en) 2013-09-19
HRP20171579T8 (hr) 2018-12-14
EP3192803A1 (en) 2017-07-19
JP2017132770A (ja) 2017-08-03
US20150024997A1 (en) 2015-01-22
DK2680873T3 (en) 2017-10-30
HRP20171579T1 (hr) 2018-02-09
JP2014516339A (ja) 2014-07-10
CA2865791A1 (en) 2012-09-07

Similar Documents

Publication Publication Date Title
HRP20171579T8 (hr) Antigljivična sredstva i njihova upotreba
IL233051B (en) Anti-phf-tau antibodies and uses thereof
PL2691443T3 (pl) Sprzężone lipomery i ich zastosowania
EP2552953A4 (en) FRIZZLED-BINDING SUBSTANCES AND ITS USES
IL229844B (en) Anti-psgl-1 antibodies and their use
HK1201454A1 (en) Therapeutic agents and uses thereof
HK1191034A1 (en) N-carboxyalkyl-auristatins and use thereof n-
IL231082A (en) Pyrimido compounds - pyridazinone and their use
EP2699272A4 (en) CONTRAST AGENTS AND USES THEREOF
EP2928875A4 (en) FUNGICIDE COMPOUND AND USES THEREOF
EP2688412A4 (en) INSECTICIDES AND APPLICATIONS THEREOF
HK1190713A1 (zh) 外用抗真菌劑
EP2688588A4 (en) FAST AND LONG-TERM IMMUNOLOGICAL THERAPEUTIC
EP2697386A4 (en) DESIGN AND USE OF PEPDUCINE
HK1192116A1 (zh) 殺蟲組合物及其相關方法
GB201111775D0 (en) Compounds and uses thereof
EP2716359A4 (en) COMPLEX AND USES THEREOF
EP2720536A4 (en) NEW AGENTS FOR COMBATING NAILS AND APPLICATIONS THEREOF
GB201106357D0 (en) Composition and uses thereof
EP2776064A4 (en) ANTAGONISTS OF PRO-VASOPRESSIN AND USES THEREOF
EP2693879A4 (en) MIGRASTATINES AND THEIR USES
EP2704579A4 (en) SCRAP CONTROL AND APPLICATIONS THEREOF
HK1254681A1 (zh) 抗真菌劑
EP2605770A4 (en) ANTIFUNGAL AGENTS AND USES THEREOF
HK1201692A1 (en) Antifungal agent